期刊文献+

TNF-α基因多态性与妊娠期高血压疾病遗传易感性的研究 被引量:1

The association between polymorphism of TNF-α gene with the genetic suspectibility to hypertensive disorder complicating pregnancy
在线阅读 下载PDF
导出
摘要 目的 探讨TNF -α基因启动子 - 85 0位点C→T多态性与妊娠期高血压疾病 (hypertensivedisordercomplicat ingpregnancy)的相关性。方法 应用聚合酶链反应 -限制性片段长度多态性技术 (polymerasechainreaction -restrictionfrag mentlengthpolymorphism ,PCR -RFLP)检测 10 6例患者和 10 8例健康孕妇的TNF -α基因启动子 - 85 0位点C→T多态性。对两组之间的基因型和等位基因频率进行比较。结果 病例组CT +TT基因型在对照组明显升高 ,18.5 2 %比 7.5 5 % ,χ2 =5 .6 6 ,P =0 .0 17,OR =0 .35 9,95 %可信区间 0 .15 1- 0 .86 5 ,P <0 .0 5 ,T等位基因的发生率在两组间分别为 4 .2 5 %和 2 5 .93% ,χ2 =10 .2 9,P =0 .0 0 1,OR =0 .2 98,95 %可信区间 0 .137- 0 .6 4 8。结论 TNF -α基因启动子 - 85 0位点C→T多态性与妊娠期高血压疾病具有相关性 ,- 85 0位点的突变可能是保护性因素。 Objective: To study whether the development of hypertensive disorder complicating pregnancy is associated with-850C→T mutation at promoter of TNF-α gene. Methods: The -850C→T polymorphism of all the cases were detected by means of PCR-RFLP techniques. Compared the genotype and allele frequencies between patients and controls. Results: A significant different genotype distribution of -850C→T polymorphism was observed between the two groups. Compared with the control group (18.52%), the frequency of CT and TT genotype decreased in the patient group (7.55 %) χ 2=5.66,P=0.017,OR=0.359,95% CI:0.151-0.865,P<0.05. Accordingly, the frequency of allele T in patients is 4.25%, and 25.93% in controls (χ 2=10.29,P=0.001, OR=0.298,95%CI:0.137-0.648). Conclusions: The T allele of -850 at promoter of TNF-α gene may be the protective factor against the development of the hypertensive disorder complicating pregnancy.
作者 赵茵 邹丽
出处 《中国优生与遗传杂志》 2005年第1期31-32,35,共3页 Chinese Journal of Birth Health & Heredity
基金 湖北省妇幼保健基金资助 (基金编号 :鄂卫基妇发 [2 0 0 1] 16号 )
关键词 TNF-Α 妊娠期高血压疾病 基因多态性 TNF-α Hypertensive disorder complicating pregnancy gene polymorphism
  • 相关文献

参考文献8

  • 1苟文丽.妊娠高血压综合征[A].见:乐杰主编.妇产科学[M](第6版)[C].北京:人民卫生出版社,2004.97-104.
  • 2Tadafumi Kato, Makoto Honda, Shouji Kuwata,et al. Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: no association with narcolepsy[J]. American Journal of Medical Genetics (Neuropsychiatric Genetics),1999,88(4):301-304.
  • 3Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1 beta, and interleukin 10 is increased in preeclampsia[J]. Am J Obstet Gynecol,1999,181(4):915-920.
  • 4Pang ZJ, Xing FQ. Comparative study on the expression of cytokine--receptor genes in normal and preeclamptic human placentas using DNA microarrays[J]. J Perinat Med,2003,31(2):153-62.
  • 5Anim-Nyame N, Gamble J, Sooranna SR, et al. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia[J]. Cardiovasc Res,2003,58(1):162-169.
  • 6Kupferminc M, Peaceman AM, Wigton TR, et al. Tumor necrosis factor is elevated in plasma and amniotic fluid of patients with severe preeclampsia[J]. Am J Obstet Gynecology,1994,170(6):1752-1759.
  • 7Visser W, Beckmann I, Bremer HA, Lim HL, Wallenburg HC. Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome[J]. Br J Obstet Gynaecol,1994,101(12):1081-1082.
  • 8Heiskanen J, Romppanen EL, Hiltunen M, et al. Polymorphism in the Tumor necrosis factor-α gene in women with preeclampsia[J]. J Assist Reprod Genet,2002,19(5):220-223.

共引文献4

同被引文献27

  • 1高眉扬,吴爱华,温春霞,佘达贤,陈盛强.抗原加工相关转运体基因多态性及夫妻共享率与妊娠期高血压疾病的相关性[J].中华医学遗传学杂志,2006,23(2):165-168. 被引量:5
  • 2Pfab T, Chen YP, Slowinski T, et al Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy[ J]. Hypertens,2005 ,23 :2187-2191.
  • 3Shiroishi M, Tsumoto K, Amano K, et al. Human inhibitory receptors Ig - like transeript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind p referentially to HLA - G[ J ]. Proc Nail Acad Sci U S A, 2003, 100(15) : 8856-8861.
  • 4Emmer PM, Joosten I, Schut MH, et al. Shift in expression of HLA - G mRNA spliceforms inpregnancies complicated by preeclampsia[ J ]. Journal of the Society for Gynecologic Investigation, 2004, 11 (4) :220-226.
  • 5Doher VL, Rush AN, Brennecke SP, et al. The -56T HLA-G promoter polymorphism is not associated with pre-eclampsia/eclampsia in Australian and New Zealand women [ J ]. Hypertens Pregnancy, 2006,25(2) :63-71.
  • 6Hiby SE, Walker JJ,O'shaughnbssy KM, et al. A combinations of maternal KIR and fetal HLA-C genes influence the risk of preeelampsia and reproductive success[ J ]. Exp Med ,2004,200( 8 ) , 957 -965.
  • 7Li Y, Zhao YH, Zhang WY, et al. Correlation between and pre-eclampsia. Zhonghua'Fu Chan Ke Za Zhi[ J ]. 2008 ,43(12) :909- 912.
  • 8Antoniou AN , Ford S , Pilley ES , et al . Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits [ J]. Immunology , 2002 ,106(2) :182-189.
  • 9Qing Q, Mingyan Y, Ben JK, et al. Fas ligand expression bymaternal decidual cells is negatively correlated with the abundance of leakocytes present at the maternal 3/fetal interlace[ J]. Journal of Rep roductive Immunology,2005, 65 (2) : 121 - 132.
  • 10Marzena L, Katarzyna L, Boena L, Gorzelaka and Jan Oleszczuka Evaluation of the maternal and umbilical vein serum sFas/ sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation [ J ]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2006, 126 (2) : 155 - 159.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部